Tekon Biotech will sell Labcyte systems in China, Hong Kong and Taiwan after being appointed exclusive distributor.
These include systems for compound management, high-throughput and secondary screening.
Dr Nick Samaras, managing director of Labcyte in the Asia-Pacific region, said: 'As the market moves to higher-density assays, the touchless liquid-handling capabilities offered by the Labcyte acoustic products become essential.
'In particular, the Echo liquid-handler provides superior results, reduces costs by eliminating consumables and reduces toxic wastes.
'The platform technology is also being applied in other fields, such as array formation, the microencapsulation of compounds, particle production, proteomics research, the transfer of ultra-viscous materials, cell-based biology and imaging mass spectrometry.'
